cancer

Zellfärbung erlaubt Prognose bei Brustkrebs - International Journal of Cancer, Band 123 (10), erscheint am 15. November 2008

14.11.2008, 13:35, Research / Development, Deutsches Krebsforschungszentrum

In der neuen Ausgabe des International Journal of Cancer schreiben britisch-amerikanische Forscher, dass bestimmte Zellfärbungen möglicherweise eine Prognose über...

Read more

QIAGEN Introduces CE-marked Molecular Assay for the Cancer Biomarker K-ras

11.11.2008, 09:31, Research / Development, QIAGEN GmbH

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of a new test to determine mutations of the K-ras gene. The K-ras gene is mutated...

Read more

Innovatives Raucherentwöhnungsprogramm des Tumorzentrums Ludwig Heilmeyer - Comprehensive Cancer Center Freiburg

21.10.2008, 12:29, Research / Development, Universitätsklinikum Freiburg

Das Tumorzentrum Ludwig Heilmeyer - Comprehensive Cancer Center Freiburg (CCCF) erhält eine Förderung der Pfizer-Foundation, USA, für ein völlig neuartiges Raucherentwöhnungsprogramm,...

Read more

Mammographie-Screening senkt Brustkrebssterblichkeit in den Niederlanden

21.10.2008, 09:34, Research / Development, Deutsches Krebsforschungszentrum

Nach der Einführung des Mammographie-Screening-Programms in den Niederlanden stellen Forscher eine schnelle und deutliche Senkung der Brustkrebs-Sterblichkeit fest....

Read more

The German Cancer Research Center Investigates the Role of miRNAs in Carcinogenesis Using febit's Geniom RT Analyzer

20.10.2008, 16:50, Research / Development, febit biotech gmbh

The German Cancer Research Center, also known as DKFZ, in Heidelberg (Germany) chose febit's newly introduced Geniom® RT Analyzer to investigate the association...

Read more

German Association of Gynecology and Obstetrics Recommends HPV Testing for Cervical Cancer Screening

05.08.2008, 09:28, Research / Development, QIAGEN GmbH

New cervical cancer prevention guidelines issued by the German Association for Gynecology and Obstetrics (DGGG) recommend testing women 30 and over for HPV (human...

Read more

Heritable mutations of ALK main cause of familial neuroblastoma

17.09.2008, 16:10, Biotechnology, Roche Diagnostics GmbH

Germline mutations in the anaplastic lymphoma kinase (ALK) gene explain most hereditary neuroblastomas, providing the first example of a pediatric cancer arising...

Read more

immatics receives 3 research grants totaling 1.4 mn € to advance its early-stage cancer immunotherapy programs

07.07.2008, 13:31, Research / Development, immatics biotechnologies GmbH

immatics biotechnologies GmbH today announced that the company has received grants from three renowned public research funding programs to advance its early-stage...

Read more

Skullcandy setzt sich für Brustkrebs-Vorsorge ein

10.06.2008, 18:14, Consumer Electronics, Skullcandy

Skullcandy, Hersteller von trendigen und leistungsstarken Kopfhörern, die bereits die Actionsport-Szene begeistert haben, unterstützt die Spenden-Kampagne "Boarding...

Read more

Ym Biosciences Reports Phase II Data For Nimotuzumab in Metastatic Colorectal Cancer

05.08.2008, 12:01, Medical Technology, YM BioSciences Inc.

YM BioSciences Inc. (AMEX: YMI, TSX: YM, AIM: YMBA), an oncology company that identifies, develops and commercializes differentiated products for patients worldwide,...

Read more